Dr. Dragovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 Palm Ave Ste 600
Jacksonville, FL 32207Phone+1 904-202-7300Fax+1 904-202-7433
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1997 - 2000
- Louis A Weiss Memorial HospitalResidency, Internal Medicine, 1994 - 1997
- University of Belgrade Faculty of MedicineClass of 1988
Certifications & Licensure
- AZ State Medical License 2000 - 2026
- FL State Medical License 2024 - 2026
- IL State Medical License 1997 - 2002
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2002 Jun 01
- PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2005 Dec 01
- S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304 Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 87 citationsA randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing...Ramesh K. Ramanathan, James L. Abbruzzese, Tomislav Dragovich, Lynn Kirkpatrick, Jose Guillen
Cancer Chemotherapy and Pharmacology. 2011-03-01 - 86 citationsAdjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resect...Charles S. Fuchs, Donna Niedzwiecki, Harvey J. Mamon, J. E. Tepper, Xing Ye
Journal of Clinical Oncology. 2017-10-04 - 19 citationsManagement strategies in pancreatic cancer.Christopher J Campen, Tomislav Dragovich, Amanda F. Baker
American Journal of Health-System Pharmacy. 2011-04-01
Press Mentions
- Banner MD Anderson Launches Landmark Research ExpansionFebruary 11th, 2022
Grant Support
- Clinical Trials CoreNational Cancer Institute2007–2011
- Treatment Of Hypoxia Resistance In Pancreatic Cancer - ClinicalNational Cancer Institute2005–2009
- Core -- Clinical ResourcesNational Cancer Institute2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: